Healio Taming the Tide: Management of Persistent Retinal Fluid in nAMD and DME

Details

A growing body of evidence has demonstrated the correlation between fluctuations in retinal fluid and worse anatomical and visual outcomes in patients with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) treated with intravitreal anti-vascular endothelial growth factor therapies. Appropriate selection of treatment and dosing regimens that prioritize stability of retinal anatomy while minimizing fluctuations in central retina thickness are essential for achieving optimal outcomes.

Therapies that offer longer duration of action have the potential to stabilize the retinal anatomy and minimize fluctuations in retinal fluid. In this CE activity, experts in the field will review how fluctuations in retinal fluid may negatively impact anatomical and functional outcomes in patients with nAMD and DME, as well as evaluate the latest clinical and real-world evidence for therapies that can improve retina fluid control and lessen fluctuations in central subretinal thickness. The presentation of challenging, real-world cases also allows for the application of this valuable content into clinical practice.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Describe how fluctuations in retinal fluid may negatively impact anatomical and functional outcomes in patients with nAMD and DME.
• Incorporate the latest evidence into practice about treatments that can improve retina fluid control and lessen fluctuations in central subfield thickness in nAMD and DME.

Target Audience

The intended audience for this activity is retina specialists and other healthcare professionals involved in the management of patients with nAMD and DME.

Additional credit info

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.